Psychomotor Performance and Antihypertensive Treatment

Overview

Journal Br J Clin Pharmacol

Specialty Pharmacology

Date 1994 Feb 1

PMID 8186062

Citations 1

Authors

L Kalra

C G Swift

S H Jackson

Affiliations

Soon will be listed here.

Abstract

1. The aim of treatment of hypertension is prevention of cardiovascular complications without adverse drug reactions. Psychomotor performance can be measured objectively yet there remains uncertainty concerning the psychomotor effects of antihypertensive drugs during chronic treatment. This uncertainty is partly due to the confounding adverse effects of cerebrovascular disease and hypertension itself. There are as yet insufficient good quality data on psychomotor effects with which to differentiate between the commonly used agents. However, in general, the beneficial effect of lowering blood pressure tends to more than offset any adverse effects of the agent used.

Citing Articles

Increased Force Variability Is Associated with Altered Modulation of the Motorneuron Pool Activity in Autism Spectrum Disorder (ASD).

Wang Z, Kwon M, Mohanty S, Schmitt L, White S, Christou E Int J Mol Sci. 2017; 18(4).

PMID: 28346344 PMC: 5412284. DOI: 10.3390/ijms18040698.

References

Wurzelmann J, Frishman W, Aronson M, Masur D, Ooi W . Neuropsychological effects of antihypertensive drugs. Cardiol Clin. 1987; 5(4):689-701. View

Gurland B, Teresi J, Smith W, Black D, Hughes G, Edlavitch S . Effects of treatment for isolated systolic hypertension on cognitive status and depression in the elderly. J Am Geriatr Soc. 1988; 36(11):1015-22. DOI: 10.1111/j.1532-5415.1988.tb04369.x. View

Currie D, Lewis R, McDevitt D, Nicholson A, Wright N . Central effects of beta-adrenoceptor antagonists. I--Performance and subjective assessments of mood. Br J Clin Pharmacol. 1988; 26(2):121-8. PMC: 1386519. DOI: 10.1111/j.1365-2125.1988.tb03378.x. View

Nicholson A, Wright N, Zetlein M, Currie D, McDevitt D . Central effects of beta-adrenoceptor antagonists. II--Electroencephalogram and body sway. Br J Clin Pharmacol. 1988; 26(2):129-41. PMC: 1386520. DOI: 10.1111/j.1365-2125.1988.tb03379.x. View

Richardson P, Wyke M . Memory function--effects of different antihypertensive drugs. Drugs. 1988; 35 Suppl 5:80-5. DOI: 10.2165/00003495-198800355-00014. View

Madden D, Blumenthal J . Slowing of memory-search performance in men with mild hypertension. Health Psychol. 1989; 8(2):131-42. DOI: 10.1037//0278-6133.8.2.131. View

Dietrich B, Herrmann W . Influence of cilazapril on memory functions and sleep behaviour in comparison with metoprolol and placebo in healthy subjects. Br J Clin Pharmacol. 1989; 27 Suppl 2:249S-261S. PMC: 1379755. DOI: 10.1111/j.1365-2125.1989.tb03489.x. View

Goldstein G, Materson B, Cushman W, Reda D, FREIS E, Ramirez E . Treatment of hypertension in the elderly: II. Cognitive and behavioral function. Results of a Department of Veterans Affairs Cooperative Study. Hypertension. 1990; 15(4):361-9. DOI: 10.1161/01.hyp.15.4.361. View

Bird A, Blizard R, Mann A . Treating hypertension in the older person: an evaluation of the association of blood pressure level and its reduction with cognitive performance. J Hypertens. 1990; 8(2):147-52. DOI: 10.1097/00004872-199002000-00008. View

10.

Steiner S, Friedhoff A, Wilson B, Wecker J, Santo J . Antihypertensive therapy and quality of life: a comparison of atenolol, captopril, enalapril and propranolol. J Hum Hypertens. 1990; 4(3):217-25. View

11.

Palac D, Cornish R, MCDONALD W, Middaugh D, Howieson D, Bagby S . Cognitive function in hypertensives treated with atenolol or propranolol. J Gen Intern Med. 1990; 5(4):310-8. DOI: 10.1007/BF02600398. View

12.

Blumenthal J, EKELUND L, Emery C . Quality of life among hypertensive patients with a diuretic background who are taking atenolol and enalapril. Clin Pharmacol Ther. 1990; 48(4):447-54. DOI: 10.1038/clpt.1990.174. View

13.

Currie D, Lewis R, McDevitt D, Nicholson A, Wright N . Central effects of the angiotensin-converting enzyme inhibitor, captopril. I. Performance and subjective assessments of mood. Br J Clin Pharmacol. 1990; 30(4):527-36. PMC: 1368242. DOI: 10.1111/j.1365-2125.1990.tb03810.x. View

14.

McDevitt D, Currie D, Nicholson A, Wright N, Zetlein M . Central effects of the calcium antagonist, nifedipine. Br J Clin Pharmacol. 1991; 32(5):541-9. PMC: 1368628. DOI: 10.1111/j.1365-2125.1991.tb03949.x. View

15.

Skinner M, Futterman A, Morrissette D, Thompson L, Hoffman B, Blaschke T . Atenolol compared with nifedipine: effect on cognitive function and mood in elderly hypertensive patients. Ann Intern Med. 1992; 116(8):615-23. DOI: 10.7326/0003-4819-116-8-615. View

16.

Beto J, Bansal V . Quality of life in treatment of hypertension. A metaanalysis of clinical trials. Am J Hypertens. 1992; 5(3):125-33. DOI: 10.1093/ajh/5.3.125. View

17.

Fletcher A, Bulpitt C, Chase D, Collins W, Furberg C, Goggin T . Quality of life with three antihypertensive treatments. Cilazapril, atenolol, nifedipine. Hypertension. 1992; 19(6 Pt 1):499-507. DOI: 10.1161/01.hyp.19.6.499. View

18.

Kalra L, Jackson S, Swift C . Psychomotor performance in elderly hypertensive patients. J Hum Hypertens. 1993; 7(3):279-84. View

19.

Kalra L, Jackson S, Swift C . Effect of antihypertensive treatment on psychomotor performance in the elderly. J Hum Hypertens. 1993; 7(3):285-90. View

20.

Spieth W . CARDIOVASCULAR HEALTH STATUS, AGE, AND PSYCHOLOGICAL PERFORMANCE. J Gerontol. 1964; 19:277-84. DOI: 10.1093/geronj/19.3.277. View